Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Molecular epidemiology of noroviruses in children in South Greece, 2013-2015.

Siafakas N, Zerva L, Hatzaki D, Lebessi E, Chronopoulou G, Paraskakis I, Pournaras S.

J Med Virol. 2018 Nov;90(11):1703-1711. doi: 10.1002/jmv.25251. Epub 2018 Aug 13.

PMID:
29979816
2.

Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.

Skoutelis A, Pefanis A, Tsiodras S, Sipsas NV, Lelekis M, Lazanas MC, Gargalianos P, Dalekos GN, Roilides E, Samonis G, Maltezos E, Hatzigeorgiou D, Lada M, Metallidis S, Stoupis A, Chrysos G, Karnesis L, Symbardi S, Loupa CV, Giamarellou H, Kioumis I, Sambatakou H, Tsianos E, Kotsopoulou M, Georgopali A, Liakou K, Perlorentzou S, Levidiotou S, Giotsa-Toutouza M, Tsorlini-Christoforidou H, Karaiskos I, Kouppari G, Trikka-Graphakos E, Ntrivala MA, Themeli-Digalaki K, Pangalis A, Kachrimanidou M, Martsoukou M, Karapsias S, Panopoulou M, Maraki S, Orfanou A, Petinaki E, Orfanidou M, Baka V, Stylianakis A, Spiliopoulou I, Smilakou S, Zerva L, Vogiatzakis E, Belesiotou E, Gogos CA.

PLoS One. 2017 Aug 16;12(8):e0182799. doi: 10.1371/journal.pone.0182799. eCollection 2017.

3.

Impact of bacterial load on pharmacodynamics and susceptibility breakpoints for tigecycline and Klebsiella pneumoniae.

Tsala M, Vourli S, Daikos GL, Tsakris A, Zerva L, Mouton JW, Meletiadis J.

J Antimicrob Chemother. 2017 Jan;72(1):172-180. Epub 2016 Sep 19.

PMID:
27650184
4.
5.

Concurrent Autochthonous Malaria Caused by Plasmodium vivax in Father and Son in Greece.

Dimopoulou D, Piperaki ET, Zerva L, Tsagris V, Asprogeraka S, Kalantzis D, Papaevangelou V.

J Trop Pediatr. 2017 Feb;63(1):74-77. doi: 10.1093/tropej/fmw043. Epub 2016 Jul 18.

PMID:
27435885
6.

Comparison of Short Versus Prolonged Infusion of Standard Dose of Meropenem Against Carbapenemase-Producing Klebsiella pneumoniae Isolates in Different Patient Groups: A Pharmacokinetic-Pharmacodynamic Approach.

Vourli S, Tsala M, Kotsakis S, Daikos GL, Tzouvelekis L, Miriagou V, Zerva L, Meletiadis J.

J Pharm Sci. 2016 Apr;105(4):1513-8. doi: 10.1016/j.xphs.2016.02.008.

PMID:
27019965
7.

Bioartificial liver attenuates intestinal mucosa injury and gut barrier dysfunction after major hepatectomy: Study in a porcine model.

Nastos C, Kalimeris K, Papoutsidakis N, Defterevos G, Pafiti A, Kalogeropoulou E, Zerva L, Nomikos T, Papalois A, Kostopanagiotou G, Smyrniotis V, Arkadopoulos N.

Surgery. 2016 Jun;159(6):1501-1510. doi: 10.1016/j.surg.2015.12.018. Epub 2016 Feb 2.

PMID:
26847802
8.

Pharmacokinetic-pharmacodynamic modelling of meropenem against VIM-producing Klebsiella pneumoniae isolates: clinical implications.

Tsala M, Vourli S, Kotsakis S, Daikos GL, Tzouvelekis L, Zerva L, Miriagou V, Meletiadis J.

J Med Microbiol. 2016 Mar;65(3):211-8. doi: 10.1099/jmm.0.000214. Epub 2015 Dec 23.

PMID:
26697851
9.

Bioassay for Determining Voriconazole Serum Levels in Patients Receiving Combination Therapy with Echinocandins.

Siopi M, Neroutsos E, Zisaki K, Gamaletsou M, Pirounaki M, Tsirigotis P, Sipsas N, Dokoumetzidis A, Goussetis E, Zerva L, Valsami G, Meletiadis J.

Antimicrob Agents Chemother. 2015 Oct 26;60(1):632-6. doi: 10.1128/AAC.01688-15. Print 2016 Jan.

10.

Evaluation of paper gradient concentration strips for antifungal combination testing of Candida spp.

Siopi M, Siafakas N, Zerva L, Meletiadis J.

Mycoses. 2015 Nov;58(11):679-87. doi: 10.1111/myc.12413. Epub 2015 Oct 1.

PMID:
26423198
11.

Treatment of Experimental Candida Sepsis with a Janus Kinase Inhibitor Controls Inflammation and Prolongs Survival.

Tsirigotis P, Papanikolaou N, Elefanti A, Konstantinou P, Gkirkas K, Rontogianni D, Siafakas N, Karakitsos P, Roilides E, Dimitriadis G, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2015 Dec;59(12):7367-73. doi: 10.1128/AAC.01533-15. Epub 2015 Sep 14.

12.

Activity of vancomycin, linezolid, and daptomycin against staphylococci and enterococci isolated in 5 Greek hospitals during a 5-year period (2008-2012).

Papadimitriou-Olivgeris M, Kolonitsiou F, Zerva L, Lebessi E, Koutsia C, Drougka E, Sarrou S, Giormezis N, Vourli S, Doudoulakakis A, Konsolakis C, Marangos M, Anastassiou ED, Petinaki E, Spiliopoulou I.

Diagn Microbiol Infect Dis. 2015 Dec;83(4):386-8. doi: 10.1016/j.diagmicrobio.2015.08.002. Epub 2015 Aug 5.

PMID:
26341703
13.

Evaluation of the "Dip Effect" Phenomenon in Antifungal Susceptibility Testing of Candida spp. against Echinocandins by Use of Gradient Concentration Strips.

Siopi M, Tsala M, Siafakas N, Zerva L, Meletiadis J.

J Clin Microbiol. 2015 Nov;53(11):3654-9. doi: 10.1128/JCM.02073-15. Epub 2015 Sep 2.

14.

Spectrum of enteropathogens detected by the FilmArray GI Panel in a multicentre study of community-acquired gastroenteritis.

Spina A, Kerr KG, Cormican M, Barbut F, Eigentler A, Zerva L, Tassios P, Popescu GA, Rafila A, Eerola E, Batista J, Maass M, Aschbacher R, Olsen KE, Allerberger F.

Clin Microbiol Infect. 2015 Aug;21(8):719-28. doi: 10.1016/j.cmi.2015.04.007. Epub 2015 Apr 20.

15.

Optimization of polyene-azole combination therapy against aspergillosis using an in vitro pharmacokinetic-pharmacodynamic model.

Siopi M, Siafakas N, Vourli S, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2015 Jul;59(7):3973-83. doi: 10.1128/AAC.05035-14. Epub 2015 Apr 20.

16.

Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients.

Vourli S, Frantzeskaki F, Meletiadis J, Stournara L, Armaganidis A, Zerva L, Dimopoulos G.

Int J Antimicrob Agents. 2015 Jun;45(6):670-1. doi: 10.1016/j.ijantimicag.2015.02.005. Epub 2015 Feb 26. No abstract available.

PMID:
25795317
17.

Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model--authors' response.

Siopi M, Mavridou E, Mouton JW, Verweij PE, Zerva L, Meletiadis J.

J Antimicrob Chemother. 2015 Feb;70(2):634-5. doi: 10.1093/jac/dku484. Epub 2014 Dec 8. No abstract available.

PMID:
25488075
18.

Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model.

Siopi M, Mavridou E, Mouton JW, Verweij PE, Zerva L, Meletiadis J.

J Antimicrob Chemother. 2014 Jun;69(6):1611-9. doi: 10.1093/jac/dku023. Epub 2014 Feb 17.

PMID:
24550381
19.

Susceptibility breakpoints for amphotericin B and Aspergillus species in an in vitro pharmacokinetic-pharmacodynamic model simulating free-drug concentrations in human serum.

Elefanti A, Mouton JW, Verweij PE, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2014;58(4):2356-62. doi: 10.1128/AAC.02661-13. Epub 2014 Feb 10.

20.

Molecular characterization of Streptococcus agalactiae from vaginal colonization and neonatal infections: a 4-year multicenter study in Greece.

Liakopoulos A, Mavroidi A, Vourli S, Panopoulou M, Zachariadou L, Chatzipanagiotou S, Spiliopoulou I, Zerva L, Petinaki E.

Diagn Microbiol Infect Dis. 2014 Apr;78(4):487-90. doi: 10.1016/j.diagmicrobio.2013.12.017. Epub 2014 Jan 7.

PMID:
24503505
21.

Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.

Elefanti A, Mouton JW, Verweij PE, Tsakris A, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2013 Oct;57(10):4656-63. doi: 10.1128/AAC.00597-13. Epub 2013 Jul 15.

22.

Single-dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model.

Al-Saigh R, Siopi M, Siafakas N, Velegraki A, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2013 Aug;57(8):3713-8. doi: 10.1128/AAC.02484-12. Epub 2013 May 28.

23.

Successful control of an echovirus 6 meningitis outbreak in a neonatal intensive care unit in central Greece.

Siafakas N, Goudesidou M, Gaitana K, Gounaris A, Velegraki A, Pantelidi K, Zerva L, Petinaki E.

Am J Infect Control. 2013 Nov;41(11):1125-8. doi: 10.1016/j.ajic.2013.02.014. Epub 2013 May 21.

PMID:
23706831
24.

A life-threatening case of disseminated nocardiosis due to Nocardia brasiliensis.

Paramythiotou E, Papadomichelakis E, Vrioni G, Pappas G, Pantelaki M, Kontos F, Zerva L, Armaganidis A.

Indian J Crit Care Med. 2012 Oct;16(4):234-7. doi: 10.4103/0972-5229.106512.

25.

Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum.

Elefanti A, Mouton JW, Krompa K, Al-Saigh R, Verweij PE, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2013 Apr;57(4):1625-31. doi: 10.1128/AAC.01573-12. Epub 2013 Jan 14.

26.

In vitro pharmacokinetic/pharmacodynamic modeling of voriconazole activity against Aspergillus species in a new in vitro dynamic model.

Al-Saigh R, Elefanti A, Velegraki A, Zerva L, Meletiadis J.

Antimicrob Agents Chemother. 2012 Oct;56(10):5321-7. doi: 10.1128/AAC.00549-12. Epub 2012 Aug 6.

27.

Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.

Meletiadis J, Al-Saigh R, Velegraki A, Walsh TJ, Roilides E, Zerva L.

Antimicrob Agents Chemother. 2012 Jan;56(1):403-10. doi: 10.1128/AAC.00662-11. Epub 2011 Nov 7.

28.

Molecular detection and identification of enteroviruses in children admitted to a university hospital in Greece.

Siafakas N, Attilakos A, Vourli S, Stefos E, Meletiadis J, Nikolaidou P, Zerva L.

Mol Cell Probes. 2011 Oct-Dec;25(5-6):249-54. doi: 10.1016/j.mcp.2011.06.001. Epub 2011 Jul 23.

PMID:
21803150
29.

Recurrent fluctuant mass of the wrist and forearm associated with chronic tenosynovitis by Mycobacterium kansasii.

Mazis GA, Sakellariou VI, Kontos F, Zerva L, Spyridonos SG.

Orthopedics. 2011 May 18;34(5):400. doi: 10.3928/01477447-20110317-23.

PMID:
21598885
30.

Staphylococcus lugdunensis strain with a modified PBP1A/1B expressing resistance to ╬▓-lactams.

Kotsakis SD, Tzouvelekis LS, Zerva L, Liakopoulos A, Petinaki E.

Eur J Clin Microbiol Infect Dis. 2012 Feb;31(2):169-72. doi: 10.1007/s10096-011-1289-8. Epub 2011 May 19.

PMID:
21594555
31.

Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates.

Meletiadis J, Arabatzis M, Bompola M, Tsiveriotis K, Hini S, Petinaki E, Velegraki A, Zerva L.

J Clin Microbiol. 2011 Jul;49(7):2722-7. doi: 10.1128/JCM.01253-10. Epub 2011 May 4.

32.

Linezolid-resistant enterococci in Greece: epidemiological characteristics.

Spiliopoulou I, Damani A, Chini V, Zerva L, Kolonitsiou F, Anastassiou ED, Petinaki E.

Chemotherapy. 2011;57(3):181-5. doi: 10.1159/000326444. Epub 2011 Apr 6.

PMID:
21474928
33.

Polyphasic identification and susceptibility to seven antifungals of 102 Aspergillus isolates recovered from immunocompromised hosts in Greece.

Arabatzis M, Kambouris M, Kyprianou M, Chrysaki A, Foustoukou M, Kanellopoulou M, Kondyli L, Kouppari G, Koutsia-Karouzou C, Lebessi E, Pangalis A, Petinaki E, Stathi A, Trikka-Graphakos E, Vartzioti E, Vogiatzi A, Vyzantiadis TA, Zerva L, Velegraki A.

Antimicrob Agents Chemother. 2011 Jun;55(6):3025-30. doi: 10.1128/AAC.01491-10. Epub 2011 Mar 28.

34.

Antioxidant treatment attenuates intestinal mucosal damage and gut barrier dysfunction after major hepatectomy. Study in a porcine model.

Nastos C, Kalimeris K, Papoutsidakis N, Defterevos G, Pafiti A, Kalogeropoulou H, Zerva L, Nomikos T, Kostopanagiotou G, Smyrniotis V, Arkadopoulos N.

J Gastrointest Surg. 2011 May;15(5):809-17. doi: 10.1007/s11605-011-1475-0. Epub 2011 Mar 5.

PMID:
21380631
35.

Aminoglycoside-resistant staphylococci in Greece: prevalence and resistance mechanisms.

Liakopoulos A, Foka A, Vourli S, Zerva L, Tsiapara F, Protonotariou E, Dailiana Z, Economou M, Papoutsidou E, Koutsia-Carouzou C, Anastassiou ED, Diza E, Zintzaras E, Spiliopoulou I, Petinaki E.

Eur J Clin Microbiol Infect Dis. 2011 May;30(5):701-5. doi: 10.1007/s10096-010-1132-7. Epub 2011 Jan 9. No abstract available.

PMID:
21222013
36.

Two successfully treated cases of Staphylococcus lugdunensis endocarditis.

Chatzigeorgiou KS, Ikonomopoulou C, Kalogeropoulou S, Siafakas N, Giannopoulos G, Antoniadou A, Tassios PT, Tarpatzi E, Giannitsioti E, Vlachakos D, Ikonomopoulos T, Petinaki E, Zerva L.

Diagn Microbiol Infect Dis. 2010 Dec;68(4):445-8. doi: 10.1016/j.diagmicrobio.2010.07.018.

PMID:
21094427
37.

Identification of staphylococci by Phoenix: validation of a new protocol and comparison with Vitek 2.

Chatzigeorgiou KS, Siafakas N, Petinaki E, Argyropoulou A, Tarpatzi A, Bobola M, Paniara O, Velegraki A, Zerva L.

Diagn Microbiol Infect Dis. 2010 Dec;68(4):375-81. doi: 10.1016/j.diagmicrobio.2010.08.010.

PMID:
21094424
38.

Association of target organ damage with three arterial stiffness indexes according to blood pressure dipping status in untreated hypertensive patients.

Triantafyllidi H, Tzortzis S, Lekakis J, Ikonomidis I, Arvaniti C, Trivilou P, Kontsas K, Siafakas N, Zerva L, Stamboulis E, Kremastinos D, Anastasiou-Nana M.

Am J Hypertens. 2010 Dec;23(12):1265-72. doi: 10.1038/ajh.2010.156. Epub 2010 Jul 29.

PMID:
20671719
39.

Mycobacterium arupense pulmonary infection: antibiotic resistance and restriction fragment length polymorphism analysis.

Neonakis IK, Gitti Z, Kontos F, Baritaki S, Petinaki E, Baritaki M, Liakou V, Zerva L, Spandidos DA.

Indian J Med Microbiol. 2010 Apr-Jun;28(2):173-6. doi: 10.4103/0255-0857.62502.

40.

fbl gene as a species-specific target for Staphylococcus lugdunensis identification.

Chatzigeorgiou KS, Siafakas N, Petinaki E, Zerva L.

J Clin Lab Anal. 2010;24(2):119-22. doi: 10.1002/jcla.20352.

PMID:
20333760
41.

An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.

Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T, Vourli S, Zerva L, Armaganidis A, Kanellakopoulou K, Giamarellou H.

Clin Infect Dis. 2010 Feb 1;50(3):364-73. doi: 10.1086/649865.

PMID:
20041768
42.

A newly described vancomycin-resistant ST412 Enterococcus faecium predominant in Greek hospitals.

Damani A, Klapsa D, Panopoulou M, Spiliopoulou I, Pantelidi K, Malli E, Kolonitsiou F, Grapsa S, Alepopoulou E, Frantzidou F, Vlahaki E, Koutsia-Carouzou C, Malamou-Lada H, Zerva L, Kartali-Ktenidou S, Anastassiou ED, Maniatis AN, Petinaki E.

Eur J Clin Microbiol Infect Dis. 2010 Mar;29(3):329-31. doi: 10.1007/s10096-009-0847-9. Epub 2009 Dec 17.

PMID:
20016994
43.

Mycobacterium thermoresistibile: case report of a rarely isolated mycobacterium from Europe and review of literature.

Neonakis IK, Gitti Z, Kontos F, Baritaki S, Petinaki E, Baritaki M, Zerva L, Spandidos DA.

Indian J Med Microbiol. 2009 Jul-Sep;27(3):264-7. doi: 10.4103/0255-0857.53214. Review.

44.

Nocardia puris endophthalmitis.

Papaventsis D, Siafakas N, Kondyli L, Akritidou M, Pantazi P, Perdikari E, Bethimoutis G, Chatzakis G, Zerva L.

Indian J Med Microbiol. 2009 Apr-Jun;27(2):168-70. doi: 10.4103/0255-0857.49438. No abstract available.

45.

Report of 2 indigenous cases of leprosy from a European country: use of polymerase chain reaction-restriction fragment length polymorphism analysis of hsp65 gene for identification of Mycobacterium leprae directly from a clinical sample.

Neonakis IK, Gitti Z, Kontos F, Baritaki S, Zerva L, Krambovitis E, Spandidos DA.

Diagn Microbiol Infect Dis. 2009 Jul;64(3):331-3. doi: 10.1016/j.diagmicrobio.2009.03.006. Epub 2009 Apr 18.

PMID:
19376672
46.

Cognitive impairment is related to increased arterial stiffness and microvascular damage in patients with never-treated essential hypertension.

Triantafyllidi H, Arvaniti C, Lekakis J, Ikonomidis I, Siafakas N, Tzortzis S, Trivilou P, Zerva L, Stamboulis E, Kremastinos DT.

Am J Hypertens. 2009 May;22(5):525-30. doi: 10.1038/ajh.2009.35. Epub 2009 Mar 5.

PMID:
19265790
47.

Association of the dopamine D3 receptor Ser9Gly and of the serotonin 2C receptor gene polymorphisms with tardive dyskinesia in Greeks with chronic schizophrenic disorder.

Rizos EN, Siafakas N, Katsantoni E, Lazou V, Sakellaropoulos K, Kastania A, Kossida S, Chatzigeorgiou KS, Arsenis G, Zerva L, Katsafouros K, Lykouras L.

Psychiatr Genet. 2009 Apr;19(2):106-7. doi: 10.1097/YPG.0b013e32832080ad. No abstract available.

PMID:
19106782
48.

Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis.

Souli M, Sakka V, Galani I, Antoniadou A, Galani L, Siafakas N, Zerva L, Fytrou H, Tsiodras S, Giamarellou H.

Int J Antimicrob Agents. 2009 Feb;33(2):137-42. doi: 10.1016/j.ijantimicag.2008.08.017. Epub 2008 Nov 13.

PMID:
19013056
49.

In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.

Malli E, Spiliopoulou I, Kolonitsiou F, Klapsa D, Giannitsioti E, Pantelidi K, Pratti A, Panopoulou M, Grapsa S, Alepopoulou E, Neonakis I, Frantzidou F, Alexiou-Daniel S, Bakola D, Koutsia-Carouzou C, Malamou-Lada H, Zerva L, Vlahaki E, Kartali-Ktenidou S, Anastassiou ED, Petinaki E.

Int J Antimicrob Agents. 2008 Dec;32(6):525-8. doi: 10.1016/j.ijantimicag.2008.05.020. Epub 2008 Sep 5.

PMID:
18774268
50.

In vitro activity of tigecycline against gram-positive cocci: a multicentre study in Greece.

Malli E, Spiliopoulou I, Kolonitsiou F, Neocleous Ch, Klapsa D, Pantelidi K, Panopoulou M, Grapsa S, Alepopoulou E, Neonakis I, Alexiou-Daniel S, Bakola D, Koutsia-Carouzou C, Malamou-Lada H, Zerva L, Vlahaki E, Kartali-Ktenidou S, Anastassiou E, Petinaki E.

J Antimicrob Chemother. 2008 Nov;62(5):1158-60. doi: 10.1093/jac/dkn344. Epub 2008 Aug 27. No abstract available.

PMID:
18753190

Supplemental Content

Support Center